Earnings · China A-shares
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A (000999) earnings
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-23: net profit -8.30% year on year, -5.48% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +0.52% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-23
- Period end
- 2026-09-30
- Net profit YoY
- -8.30%
- Excl. one-offs YoY
- -5.48%
- Net profit QoQ
- -18.16%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.09% | — |
| 3 days | +0.52% | — |
| 7 days | +4.40% | — |
| 14 days | +1.05% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 3 of 8 reports (average -1.22%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-24 | ¥2.16B | -8.30% | -5.48% | -2.62% | 1.30 | 9.46% | +0.52% | — | — |
| 2026 interim report | 2026-08-22 | ¥1.67B | -7.96% | -5.93% | +1.37% | 1.00 | 7.31% | +1.28% | +4.72% | +11.64% |
| 2026 Q1 report | 2026-04-25 | ¥1.08B | -15.29% | -13.96% | +18.62% | 0.65 | 4.74% | -4.01% | -9.83% | -9.53% |
| 2025 annual report | 2026-03-21 | ¥3.42B | +1.58% | +0.52% | +14.43% | 2.06 | 16.07% | -3.85% | -13.17% | -20.35% |
| 2025 Q3 report | 2025-10-25 | ¥2.35B | -20.51% | -20.56% | +11.38% | 1.42 | 11.47% | -1.64% | -3.35% | -3.12% |
| 2025 interim report | 2025-08-16 | ¥1.82B | -24.31% | -26.46% | +4.99% | 1.09 | 8.80% | -2.72% | -9.04% | -17.34% |
| 2025 Q1 report | 2025-04-29 | ¥1.27B | -6.87% | -8.25% | -6.04% | 0.77 | 6.18% | -1.74% | -24.73% | -27.31% |
| 2024 annual report | 2025-03-13 | ¥3.37B | +18.05% | +15.01% | +11.63% | 2.02 | 17.33% | +2.43% | +6.43% | +11.60% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.